About Us
Company Overview
Vision / Mission / Values
Leadership
Clinical Advisory Board
Partnering
Our Approach
Technologies
Manufacturing
Publications
Pipeline
Pipeline
Autologous CAR-T
Allogeneic CAR-T
Expanded Access
Investors
Announcements
Corporate Governance
Corporate Deck & Presentations
Webcasts
Presentations
Financial Reports
Listing Documents
IR Contact
Newsroom
Careers
Join Us
Contact Us
EN
简
About Us
Company Overview
Vision / Mission / Values
Leadership
Clinical Advisory Board
Partnering
Our Approach
Technologies
Manufacturing
Publications
Pipeline
Pipeline
Autologous CAR-T
Allogeneic CAR-T
Expanded Access
Investors
Announcements
Corporate Governance
Corporate Deck & Presentations
Webcasts
Presentations
Financial Reports
Listing Documents
IR Contact
Newsroom
Careers
Join Us
Contact Us
Newsroom
Home
-
Newsroom
-
Search News
02
Jun 2025
CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting
Jun 02, 2025
28
May 2025
CARsgen’s Satri-cel Granted Priority Review by the NMPA
May 28, 2025
23
May 2025
CARsgen’s Satri-cel Abstract Available on ASCO Website
May 23, 2025
15
May 2025
CARsgen’s CT071 Abstract Published on EHA Website
May 15, 2025
12
May 2025
CARsgen Announces Preliminary Clinical Data for Allogeneic BCMA CAR-T CT0596, Demonstrating Favorable Safety and Efficacy
May 12, 2025
29
Apr 2025
EHA Preview | CARsgen
®
to Present Results of CT071 at 2024 EHA Annual Congress
Apr 29, 2025
31
Mar 2025
CARsgen
®
Announces Abstract of Satri-cel Research Results Accepted for Oral Presentation at 2025 ASCO Annual Meeting
Mar 31, 2025
19
Mar 2025
CARsgen Announced 2024 Annual Results
Mar 19, 2025
03
Mar 2025
CARsgen’s Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA
Mar 03, 2025
28
Feb 2025
CARsgen’s Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in a Patient with Autoimmune Disease
Feb 28, 2025
1
2
...
10